Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1
Author(s) -
Lei Yu,
Yingfeng Tu,
Xueling Jia,
Kun Fang,
Li Liu,
Lin Wan,
Chuanying Xiang,
Yanan Wang,
Sun Xiang-ju,
Tianyou Liu,
Dejun Yu,
Weiwei Cao,
Yinli Song,
Yuhua Fan
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000477115
Subject(s) - resveratrol , apoptosis , right ventricular hypertrophy , tunel assay , hypoxia (environmental) , pulmonary hypertension , ventricular pressure , vascular remodelling in the embryo , pulmonary artery , pharmacology , flow cytometry , mitochondrial permeability transition pore , western blot , medicine , endocrinology , chemistry , biology , blood pressure , immunology , programmed cell death , biochemistry , organic chemistry , oxygen , gene
The polyphenol resveratrol (Rev) has been found to exhibit various beneficial effects including prevention of pulmonary arterial hypertension (PAH). The present study was designed to investigate the action and potential mechanism of Rev on PAH, focusing on the role of SIRT1 (Silent Information Regulator 1) in apoptosis of pulmonary artery smooth muscle cells (PASMCs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom